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Giovacchino Pedicelli*When around 1846 the English dentist CT. Stent created
a compound capable of alleviating the discomfort of his
edentulous patients, he could not have imagined that
over the years his name would have lost the capital letter
and become synonymous with a "device" made of com-
pletely different material, destined to restore patency or
prevent the tubular anatomical structures from
collapsing.
The transition of the dental impression compound
into a surgical tool is attributable to Johannes Fredericus
Esser (1877 to 1946), a Dutch plastic surgeon who pio-
neered an innovative method of reconstructive surgery
on soldiers with face wounds during the First World
War. The material used was called "stents mold" having
already lost the capital letter in the daily use. The first
reference to a polyethylene tube “to act as a stent for the
anastomosis” in experimental biliary reconstruction in
dogs appeared in 1954. In 1966, for the first time the
term "stent" [1] appeared in literature, with reference to
a "rubber tube" inserted in the bile duct of a patient,
consisting of a material that had lost any resemblance
with that of Dr. Stent. In the same year the notion of
stent found its way into cardiology: Weldon et al. [2]
described "a prosthetic-stented aorthic homograft used
for mitral valve replacement. . .", where the term stent
was referred to "any kind of non-biological support used
to give shape or form to biological tissue. " In 1986 the
first self-expanding coronary endoprothesis would be
implanted: that was the beginning of the triumphant era
of vascular endoprothesis!
The “Montgomery T-tube” was introduced in 1965
dedicated to the treatment of subglottic stenosis subse-
quent tracheal surgery: it began with the perception of
being able to overcome the numerous obstacles that can
prevent the passage of air through the tracheo-bronchial
axis by using innovative materials and technologies. The
certainty arrived in 1990’s when Dr JF Dumon created a
silicone "dedicated tracheobronchial stent". It providedCorrespondence: giopedicelli@libero.it
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reproduction in any medium, provided the orspecific characteristics: a flexible shape able to reproduce
the natural tracheobronchial lumen; strength to oppose
the oppression by expansive intra-extra parietal pro-
cesses, blunt ends to prevent parietal injury caused by
respiratory acts, provided with small protuberances on
the outer wall to facilitate adhesion to the mucosa, pre-
venting migration.
The stent created by Dumon marks the entrance into
the modern era as far as the aim of ensuring the patency
of the central airways is concerned; it will undergo sev-
eral adjustments over the subsequent years, the largest
one of which will be the use of self-expanding structure
and / or materials in order to endorse adhesion, stability
and efficiency of the prosthetic device, managed in the
most appropriate way by interventional bronchoscopy.
Regardless of the ongoing improvements there is still no
ideal stent for the airways - and perhaps talking about it
isn’t significant - because of the varied nature of the
stenoses and their possible changes even during therapy.
The treatment of airway obstruction by stent essen-
tially passes through three phases, each of which should
be driven by clinicians. The first step is a thorough
radiological assessment perfected by bronchoscopy, fol-
lowed by the stent choice, and its placement and finally
the follow up for detection and treatment of possible
complications.
The advent of Multidetector Computed Tomography
(MDCT) has dramatically transformed the non-invasive
diagnostic imaging of the airways offering anatomical
patterns in vivo; interventional radiology procedures
and, most of all, stent placement have experienced a
great acceleration. Bronchoscopy remains the strategic
procedure for the central airways, nevertheless MDCT
imaging plays an essential role in the planning and guid-
ance of bronchoscopic interventions and, most of all,
providing a non invasive method for postprocedural sur-
veillance. Volumetric isotropic acquisition ensures the
detection of structures with a uniform geometry and
high spatial resolution in all planes providing an ex-
tremely accurate anatomical documentation: it can be. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Pedicelli. Multidisciplinary Respiratory Medicine 2012, 7:20 Page 2 of 2
http://www.mrmjournal.com/content/7/1/20considered a problem solving tool. Paired inspiratory
and dynamic expiratory MDCT imaging, along with
newer cine CT imaging methods, have enhanced the as-
sessment of tracheobronchomalacia in both adults and
the pediatric population, increasing its diagnostic
detection.
The systematic use of MDCT allows accurate prelim-
inary depiction of the airways on three spatial planes
with the aim of evaluating the nature of the stenosis to
be treated, as well as its dimension, configuration and
calibre. This preliminary study will be used by the inter-
ventional bronchoscopist for the most proper stent
choice according to the clinical case. The goals to
achieve (increasing the calibre of the airway, opposing
the invasiveness of the expansive process, extended or
localized, favouring the intraluminal debulking process
of an invasive tumour, stabilizing of a condition of tra-
cheobronchomalacia, sealing a tracheo-oesophageal fis-
tula etc.) will be assessed in advance with careful
evaluation of the overall pathological situation provided
by MDCT, as well as with endoscopic observation. Al-
though, on the basis of statistical results released so far,
some Institutions are providing “recommendations” con-
cerning the stent choice, it is the operator who must
make the final choice, taking into account the specific
situation of the patient. Moreover, even the imaging tim-
ing for re-evaluation of the stent condition, its relation-
ships to the tracheobronchial wall and the possible
complications, should be set by the bronchoscopist, pre-
ferably in agreement with the clinician and the radiolo-
gist. For example, the monitoring of a provisional stent
(debulking of bulky tumors, treatment of transient or
stabilized stenoses) must take into account the anatom-
ical situation adjacent to the stenosis, even beyond the
tracheobronchial tree.
Thus, MDCT has proven to be the most appropriate
non invasive routine surveillance method in patients
with airway stents [3], with a wider and longer vision
compared to the endoscopic assessment of adverse
events and complications: the continuous display of
stents aids identification of stent complications, includ-
ing migration, fracture, intraluminal granulation tissue
and malignant proliferation.
The study by Ozgul et al. [4] describes the potential of
MDCT through adequate clinical examples and two-
dimensional imaging of the central airway stenting in
helping to overcome the limitations of axial CT to
visualize contemporarily the airways, the prosthesic
stents by more accurately depicting the craniocaudal ex-
tent of airway abnormalities, improving the detection of
subtle areas of stenosis, and helping to elucidate com-
plex anatomic relationships.
I believe that the article’s most valuable quality is its
contribution to familiarizing clinicians with this issue.The effectiveness of images, the procedures’ feasibility
and the fidelity of the resulting images are very convin-
cing, suggesting a development of clinical indications for
treatments [5].
It is reasonable to assume that the gradual growth of
confidence in the procedures and, above all, clinical-
radiological-interventional specialities, will effectively
contribute to improve patient selection and optimize
decision-making measures in order to reduce complica-
tions and improve the quality of life of patients.
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